ciprofloxacin has been researched along with Adenoma, Prostatic in 9 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fleroxacin is a new fluoroquinolone with a broad antibacterial spectrum and a serum half-life of about 8-12 h." | 5.27 | In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue. ( Grobecker, H; Kees, F; Metz, R; Naber, KG; Schumacher, H; Sörgel, F, 1988) |
| "Ofloxacin has the advantage against ciprofloxacin of exceeding the MICs for Staphylococcus and Chlamydia." | 1.30 | A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion. ( Cheng, C; Foo, KT; Li, MK; Png, JC; Rekhraj, IR; Tan, E, 1997) |
| "Forty-four patients with benign prostatic hypertrophy treated with transurethral resection of the prostate were entered in this study." | 1.28 | [Ciprofloxacin concentration in human prostatic tissue following 3 days' administration]. ( Morita, M; Nakagawa, H; Suzuki, K, 1991) |
| "Fleroxacin is a new fluoroquinolone with a broad antibacterial spectrum and a serum half-life of about 8-12 h." | 1.27 | In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue. ( Grobecker, H; Kees, F; Metz, R; Naber, KG; Schumacher, H; Sörgel, F, 1988) |
| "The drug levels in prostatic adenoma tissue were similar to the concomitantly measured plasma levels." | 1.27 | Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue. ( Grobecker, H; Kees, F; Naber, KG; Schumacher, H, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elshal, AM | 1 |
| Atwa, AM | 1 |
| El-Nahas, AR | 1 |
| El-Ghar, MA | 1 |
| Gaber, A | 1 |
| Elsawy, E | 1 |
| Hashem, A | 1 |
| Farag, Y | 1 |
| Farg, H | 1 |
| Elsorougy, A | 1 |
| Fouda, M | 1 |
| Nabeeh, H | 1 |
| Mosbah, A | 1 |
| Jichlinski, P | 1 |
| Santucci, R | 1 |
| Bouayad-Agha, K | 1 |
| Maloisel, F | 1 |
| Couturier, F | 1 |
| Png, JC | 1 |
| Tan, E | 1 |
| Foo, KT | 1 |
| Li, MK | 1 |
| Cheng, C | 1 |
| Rekhraj, IR | 1 |
| Tuhkanen, K | 1 |
| Heino, A | 1 |
| Ala-Opas, M | 1 |
| Morita, M | 1 |
| Nakagawa, H | 1 |
| Suzuki, K | 1 |
| Grabe, M | 1 |
| Forsgren, A | 1 |
| Björk, T | 1 |
| Naber, KG | 2 |
| Sörgel, F | 1 |
| Kees, F | 2 |
| Schumacher, H | 2 |
| Metz, R | 1 |
| Grobecker, H | 2 |
2 trials available for ciprofloxacin and Adenoma, Prostatic
| Article | Year |
|---|---|
Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Large-Core Needle; Bloo | 2018 |
Contact laser prostatectomy compared to TURP in prostatic hyperplasia smaller than 40 ml. Six-month follow-up with complex urodynamic assessment.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Follow-Up Studies; Humans; Laser Therapy; Male; Middle A | 1999 |
7 other studies available for ciprofloxacin and Adenoma, Prostatic
| Article | Year |
|---|---|
[Urology in 2011].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Anti-Bacterial Agents; Anti-Infective Ag | 2012 |
[Ciprofloxacin-induced thrombopenia].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Male; Middle Aged; Platelet Count; Prostatic Hyperplas | 2012 |
A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion.
Topics: Administration, Oral; Anti-Infective Agents; Anti-Infective Agents, Urinary; Chromatography, High Pr | 1997 |
[Ciprofloxacin concentration in human prostatic tissue following 3 days' administration].
Topics: Administration, Oral; Aged; Aged, 80 and over; Ciprofloxacin; Humans; Male; Middle Aged; Premedicati | 1991 |
Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Postoperative Compli | 1986 |
In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Body Fluids; Ciprofloxacin; Fleroxacin; Gram- | 1988 |
Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue.
Topics: Administration, Oral; Aged; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Humans; | 1988 |